UnknownNot applicableNCT02424669

Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique Hopitaux De Marseille
Principal Investigator
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Intervention
ALS Functional rating Scale-revised (ALS FRS-R)(other)
Enrollment
100 enrolled
Eligibility
18-80 years · All sexes
Timeline
2015 – 2018

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02424669 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis →

← Back to all trials